ADXS Advaxis Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ADXS

Price (delayed)

$0.46

Market cap

$54.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.32

Enterprise value

$27.42M

Sector: Healthcare
Industry: Biotechnology
Website: https://www.advaxis.com/

Highlights

Advaxis's EPS has soared by 89% YoY and by 26% from the previous quarter
ADXS's revenue has soared by 56% YoY
ADXS's equity is up by 25% QoQ but it is down by 10% YoY

Key stats

What are the main financial stats of ADXS
Market
Shares outstanding
119.47M
Market cap
$54.95M
Enterprise value
$27.42M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.37
Price to sales (P/S)
20.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.7
Earnings
Revenue
$1.87M
EBIT
-$22.54M
EBITDA
-$20.92M
Free cash flow
-$17.02M
Per share
EPS
-$0.32
Free cash flow per share
-$0.2
Book value per share
$0.34
Revenue per share
$0.02
TBVPS
$0.51
Balance sheet
Total assets
$45.95M
Total liabilities
$8.37M
Debt
$5.79M
Equity
$37.58M
Working capital
$31.95M
Liquidity
Debt to equity
0.15
Current ratio
9.93
Quick ratio
9.31
Net debt/EBITDA
1.32
Margins
EBITDA margin
-1,121.8%
Gross margin
100%
Net margin
-1,211.2%
Operating margin
-1,207.8%
Efficiency
Return on assets
-53.2%
Return on equity
-67.1%
Return on invested capital
-165.1%
Return on capital employed
-53.2%
Return on sales
-1,208.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ADXS stock price

How has the Advaxis stock price performed over time
Intraday
-2.13%
1 week
-22.03%
1 month
-45.24%
1 year
-26.98%
YTD
31.43%
QTD
-37.84%

Financial performance

How have Advaxis's revenue and profit performed over time
Revenue
$1.87M
Gross profit
$1.87M
Operating income
-$22.53M
Net income
-$22.59M
Gross margin
100%
Net margin
-1,211.2%
The net margin has surged by 88% since the previous quarter and by 61% year-on-year
Advaxis's operating margin has surged by 88% QoQ and by 60% YoY
ADXS's revenue has soared by 56% YoY
The gross profit has soared by 56% YoY

Growth

What is Advaxis's growth rate over time

Valuation

What is Advaxis stock price valuation
P/E
N/A
P/B
1.37
P/S
20.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.7
Advaxis's EPS has soared by 89% YoY and by 26% from the previous quarter
The P/B is 26% below the 5-year quarterly average of 1.9 but 8% above the last 4 quarters average of 1.3
ADXS's equity is up by 25% QoQ but it is down by 10% YoY
The P/S is 85% lower than the 5-year quarterly average of 143.7 and 79% lower than the last 4 quarters average of 102.9
ADXS's revenue has soared by 56% YoY

Efficiency

How efficient is Advaxis business performance
Advaxis's ROS has soared by 88% from the previous quarter and by 61% YoY
Advaxis's return on invested capital has surged by 68% YoY and by 9% QoQ
ADXS's ROA is up by 28% YoY and by 12% from the previous quarter
The company's return on equity rose by 22% YoY and by 12% QoQ

Dividends

What is ADXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADXS.

Financial health

How did Advaxis financials performed over time
The quick ratio has grown by 22% from the previous quarter and by 9% YoY
The total assets has grown by 19% from the previous quarter but it has contracted by 11% YoY
The debt is 85% smaller than the equity
ADXS's debt to equity is down by 25% from the previous quarter and by 6% YoY
ADXS's equity is up by 25% QoQ but it is down by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.